510(k) Report

510(k) · Cleared

Recalled · 2011

Wittmann Patch

K093166510(k) TraditionalCleared Dec 7, 200962-day reviewClass II21 CFR 878.3300Recalls 2

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Aperta, LLC · FTL Mesh, Surgical, Polymeric

Cleared on Dec 7, 2009 as substantially equivalent to K983753 (Osteogenics, Inc., 1999) after a 62-day review. Its family tree reaches back 1 generation to 1999. It has been recalled 2 times.

Decided
Dec 7, 2009
Review
62 days
Class
Class II
Product code
FTL
Recalls
2
Predicates
1

Its longest line of descent runs back 1 generation to K983753 (1999). No later device cites it as a predicate yet.

K983753 · Star Temporary Wound Cover · Osteogenics, Inc. · 19991995200020052010
K983753 · Star Temporary Wound Cover · Osteogenics, Inc. · 19990
  1. Root · 1 generation backK983753 Star Temporary Wound CoverOsteogenics, Inc. · 1999
  2. This deviceK093166 Wittmann PatchAperta, LLC · 2009
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−1K983753Star Temporary Wound CoverOsteogenics, Inc.1999—
0 (this device)K093166Wittmann PatchAperta, LLC2009—
FIG. 1 — Lineage of K093166, 1999–2009Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in FTL? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new FTL device

  1. #1 K220091 Poly-Tape/Infinity-Lock Soft Tissue…score 16.8 · 14 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (2)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K983753Star Temporary Wound Cover
Summary page 1
…the United States: "STAR TEMPORARY WOUND COVER" (Trade name: WITTMANN PATCH) permitted for Osteogenics, Inc. on 11/18/1999 with the 510(k) approval Number K(983753 2) in Europe) CE marketed product: ARTIFICIAL BUR FOR TEMPORARY ABDOMINAL CLOSURE (Trade name: WITTMANN PATCH) permit…
Osteogenics, Inc.1999—
*—ARTIFICIAL BUR FOR TEMPORARY ABDOMINAL CLOSURE (Trade name: WITTMANN PATCH)
Named without a submission number
—

Also cleared against K983753: 1 other device →

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

Recalls of this device

DateClassRecallRoot causeReason
Jun 22, 2011Not classifiedZ-0919-2012Process change controlOn 06/22/2011 Novomedicus, FL initiated a recall of the Artificial Bur Hypopack Lot 1010.1, 1102.1, 1103.1 and 5643.2. Cytotoxicity testing revealed a biocompatibility issue. The test results did not represent a health risk.
Jun 22, 2011Not classifiedZ-0920-2012Process change controlOn 06/22/2011 Novomedicus, FL initiated a recall of the Artificial Bur Hypopack Lot 1010.1, 1102.1, 1103.1 and 5643.2. Cytotoxicity testing revealed a biocompatibility issue. The test results did not represent a health risk.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • Its one ancestor has no recall.
  • 1 other device also cites its predicate K983753.

How does its category compare?

All FTL devices

FTL Mesh, Surgical, Polymeric: FDA decisions, review times, recalls and adverse event reports over 20 years. 2009, this device’s year, is highlighted.

FDA decisions per year · FTL

6in 2025

2007: 202008: 232009: 152010: 182011: 152012: 122013: 82014: 112015: 122016: 32017: 62018: 122019: 42020: 52021: 22022: 62023: 42024: 22025: 62026 (partial year): 2
2007high 23 (2008) · low 2 (2021)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · FTL

30in 2025

2007: 92 days median2008: 114 days median2009: 97 days median2010: 132 days median2011: 90 days median2012: 213 days median2013: 90 days median2014: 70 days median2015: 121 days median2016: 186 days median2017: 132 days median2018: 105 days median2019: 99 days median2020: 138 days median2022: 195 days median2023: 29 days median2025: 30 days median
2007high 213 (2012) · low 29 (2023)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · FTL

1in 2020

2007: 22008: 12009: 12010: 122011: 82012: 22013: 12014: 32017: 12018: 12020: 1
2007high 12 (2010) · low 0 (2015)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · FTL

3,487in 2025

2007: 1,7372008: 1,5692009: 1,9062010: 2,1752011: 3,6082012: 14,7002013: 26,5192014: 2,6832015: 2,5262016: 2,4172017: 3,9472018: 11,8932019: 21,7242020: 18,8192021: 16,2842022: 11,4392023: 8,0252024: 8,5652025: 3,487
2007high 26,519 (2013) · low 1,569 (2008)2025

MAUDE reports naming product code FTL, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
2007209221,737
20082311411,569
2009159711,906
201018132122,175
2011159083,608
201212213214,700
2013890126,519
2014117032,683
20151212102,526
2016318602,417
2017613213,947
201812105111,893
2019499021,724
20205138118,819
20212—016,284
20226195011,439
202342908,025
20242—08,565
202563003,487
20262—0—

What is it indicated for?

1) Advanced intra-abdominal pathology requiring more than one abdominal operation to control the disease. As fascia expander prosthesis to temporarily close the abdominal cavity when regular abdominal closure is not possible because abdominal organs protrude due to massive swelling of tissues, e.g. abdominal compartment syndrome and other severe and life threatening abdominal pathology.

2) To prevent perfusion impairment of abdominal organs from increased intra-abdominal pressure.

3) Advanced intra-abdominal pathology requiring more than one abdominal operation to control the disease process.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K093166: Wittmann Patch.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K093166

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026